INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

ADAGE CAPITAL PARTNERS GP, L.L.C.'s Holding History (CIK: 0001165408)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 438,437 Value ($000) $5,888 Avg Close — Range —
Q3 2022
Shares 50,000 Value ($000) $698 Avg Close — Range —
Q1 2022
Shares 100,000 Value ($000) $1,627 Avg Close — Range —
Q4 2021
Shares 1,233,000 Value ($000) $20,086 Avg Close — Range —
Q2 2020
Shares 550,000 Value ($000) $26,351 Avg Close — Range —
Q2 2019
Shares 333,100 Value ($000) $26,505 Avg Close — Range —
Q1 2019
Shares 505,000 Value ($000) $56,489 Avg Close — Range —
Q4 2018
Shares 138,000 Value ($000) $13,909 Avg Close — Range —
Q3 2015
Shares 77,000 Value ($000) $12,771 Avg Close — Range —
Q2 2015
Shares 87,000 Value ($000) $21,000 Avg Close — Range —
Q1 2015
Shares 111,975 Value ($000) $31,579 Avg Close — Range —
Q4 2014
Shares 120,000 Value ($000) $18,720 Avg Close — Range —
Q3 2014
Shares 41,000 Value ($000) $9,704 Avg Close — Range —
Q2 2014
Shares 15,000 Value ($000) $3,549 Avg Close — Range —
Q1 2014
Shares 55,264 Value ($000) $18,226 Avg Close — Range —
Q4 2013
Shares 175,000 Value ($000) $11,949 Avg Close — Range —
Q3 2013
Shares 410,655 Value ($000) $28,348 Avg Close — Range —
Q2 2013
Shares 438,434 Value ($000) $19,659 Avg Close — Range —
Q1 2013
Shares 288,434 Value ($000) $10,787 Avg Close — Range —